BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20473312)

  • 21. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
    Veenstra C; Karlsson E; Mirwani SM; Nordenskjöld B; Fornander T; Pérez-Tenorio G; Stål O
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1845-1856. PubMed ID: 31025094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
    Spalinger MR; McCole DF; Rogler G; Scharl M
    World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of Tregs in autoimmunity.
    Svensson MN; Doody KM; Schmiedel BJ; Bhattacharyya S; Panwar B; Wiede F; Yang S; Santelli E; Wu DJ; Sacchetti C; Gujar R; Seumois G; Kiosses WB; Aubry I; Kim G; Mydel P; Sakaguchi S; Kronenberg M; Tiganis T; Tremblay ML; Ay F; Vijayanand P; Bottini N
    J Clin Invest; 2019 Mar; 129(3):1193-1210. PubMed ID: 30620725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 25-Hydroxyvitamin D
    Zhang P; Zhang W; Zhang D; Wang M; Aprecio R; Ji N; Mohamed O; Li Y; Ding Y; Wang Q
    J Periodontal Res; 2018 Jun; 53(3):467-477. PubMed ID: 29516520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer.
    Spalinger MR; Manzini R; Hering L; Riggs JB; Gottier C; Lang S; Atrott K; Fettelschoss A; Olomski F; Kündig TM; Fried M; McCole DF; Rogler G; Scharl M
    Cell Rep; 2018 Feb; 22(7):1835-1848. PubMed ID: 29444435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
    De Keersmaecker K; Versele M; Cools J; Superti-Furga G; Hantschel O
    Leukemia; 2008 Dec; 22(12):2208-16. PubMed ID: 18784740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells.
    Huang Z; Liu M; Li D; Tan Y; Zhang R; Xia Z; Wang P; Jiao B; Liu P; Ren R
    J Biol Chem; 2020 Dec; 295(52):18343-18354. PubMed ID: 33122197
    [No Abstract]   [Full Text] [Related]  

  • 28. A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2).
    Duval R; Bui LC; Berthelet J; Dairou J; Mathieu C; Guidez F; Dupret JM; Cools J; Chomienne C; Rodrigues-Lima F
    Sci Rep; 2015 Jun; 5():10750. PubMed ID: 26040922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
    Katkeviciute E; Hering L; Montalban-Arques A; Busenhart P; Schwarzfischer M; Manzini R; Conde J; Atrott K; Lang S; Rogler G; Naschberger E; Schellerer VS; Stürzl M; Rickenbacher A; Turina M; Weber A; Leibl S; Leventhal GE; Levesque M; Boyman O; Scharl M; Spalinger MR
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33001862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
    Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
    J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-Cell-Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Comorbidities.
    Wiede F; Brodnicki TC; Goh PK; Leong YA; Jones GW; Yu D; Baxter AG; Jones SA; Kay TWH; Tiganis T
    Diabetes; 2019 Jun; 68(6):1251-1266. PubMed ID: 30936146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus.
    Houtman M; Shchetynsky K; Chemin K; Hensvold AH; Ramsköld D; Tandre K; Eloranta ML; Rönnblom L; Uebe S; Catrina AI; Malmström V; Padyukov L
    J Autoimmun; 2018 Jun; 90():28-38. PubMed ID: 29398253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural characterization of a pathogenic mutant of human protein tyrosine phosphatase PTPN2 (Cys216Gly) that causes very early onset autoimmune enteropathy.
    Nian Q; Berthelet J; Parlato M; Mechaly AE; Liu R; Dupret JM; Cerf-Bensussan N; Haouz A; Rodrigues Lima F
    Protein Sci; 2022 Feb; 31(2):538-544. PubMed ID: 34806245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
    Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
    Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing.
    Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M
    Digestion; 2016; 93(4):249-59. PubMed ID: 27115526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2.
    Scharl M; Paul G; Weber A; Jung BC; Docherty MJ; Hausmann M; Rogler G; Barrett KE; McCole DF
    Gastroenterology; 2009 Dec; 137(6):2030-2040.e5. PubMed ID: 19818778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
    Hagemeijer A; Graux C
    Genes Chromosomes Cancer; 2010 Apr; 49(4):299-308. PubMed ID: 20073070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis.
    Moore F; Colli ML; Cnop M; Esteve MI; Cardozo AK; Cunha DA; Bugliani M; Marchetti P; Eizirik DL
    Diabetes; 2009 Jun; 58(6):1283-91. PubMed ID: 19336676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TC-PTP regulates the IL-7 transcriptional response during murine early T cell development.
    Pike KA; Hatzihristidis T; Bussières-Marmen S; Robert F; Desai N; Miranda-Saavedra D; Pelletier J; Tremblay ML
    Sci Rep; 2017 Oct; 7(1):13275. PubMed ID: 29038451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.
    Song J; Lan J; Tang J; Luo N
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.